NATALIE MELNYK: Open Payments
NPI 1790141950 · FLORENCE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 19 payments from 8 companies in 2025. Trend: 2023 $1,309 · 2024 $762 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 8 | $207 |
| Collegium Pharmaceutical, Inc. | 3 | $55 |
| ABBVIE INC. | 2 | $45 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $31 |
| SCILEX PHARMACEUTICALS INC. | 2 | $30 |
| Abbott Laboratories | 1 | $23 |
| BIOTRONIK NRO, Inc. | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: WaveWriter Alpha Prime 16, Intracept, Belbuca, General - Therapies, QULIPTA, JOURNAVX, PROCLAIM, Prospera.
Industry payments across KY — which companies pay providers there.
